President/CEO
ZellNet Consulting, Inc.
Fort Lee, New Jersey
Sylvia Janetzki, MD, has dedicated the past 26 years as President and CEO of ZellNet Consulting to advancing immune monitoring approaches for clinical studies with specific focus on Elispot and sample integrity. In a tight collaboration with the Cancer Research Institute, she established international proficiency panels for Elispot, Multimer staining, and ICS. These efforts led to the publication of assay harmonization guidelines ensuring consistency and reliability across studies. Sylvia is an integral part of the MIATA core team that promotes structured and transparent reporting of immune monitoring results. Her career includes numerous publications, book chapters and a comprehensive book on Elispot. Sylvia earned her MD from Humboldt University, Berlin, and completed her post-doctoral training in Immunology at Fordham University and MSKCC.
Disclosure information not submitted.
Tuesday, July 23, 2024
2:35 PM – 3:05 PM CST